GRAIL Inc. (GRAL)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$125.24
+3.13%
Mkt Cap $5.42B
Analyst Ratings
Buy
5
Hold
3
Sell
0
Price Target (23 analysts)
$106.14
Range $56.00 – $175.00
Implied Upside
-15.2%
Consensus $106.14 vs current $125.24